ArticleReproductive biology and endocrinology : RB&E2026
Transparency only from authors? Insights from 'mysterious' retractions in obstetrics and gynecology.
Article in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Retraction of scientific papers may occur when the peer-review or publication process is compromised, even in cases where authors have no responsibility for the identified shortcomings. Using a recent case in which a peer-reviewed open-access mega-journal retracted a series of articles due to compromised peer review, also one from our group, this work examines the implications of limited editorial transparency in the retraction process. While failures in peer review can undermine the integrity of the scientific literature, inadequate communication by journal editors may have substantial negative effect on affected authors, particularly early-career researchers, including disorientation, humiliation, and a sense of perceived injustice. This analysis highlights the factors contributing to these outcomes such as the sense of loss associated with the substantial time and effort devoted to the research, as well as the practical impossibility of submitting the retracted article to alternative journals. Transparency represents a frontline defence against research misconduct but the call for increased transparency cannot be one-sided. Transparency needs to be a useful tool for the entire system, for those who report data and for those who publish data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.